Article info

Download PDFPDF

Safety and immunogenicity of a new 13-valent pneumococcal conjugate vaccine versus a licensed 7-valent pneumococcal conjugate vaccine: a study protocol of a randomised non-inferiority trial in China

Authors

  1. Correspondence to Professor Jie Lai Xia; jielaixia{at}yahoo.com
View Full Text

Citation

Chen JJ, Yuan L, Huang Z, et al
Safety and immunogenicity of a new 13-valent pneumococcal conjugate vaccine versus a licensed 7-valent pneumococcal conjugate vaccine: a study protocol of a randomised non-inferiority trial in China

Publication history

  • Received May 1, 2016
  • Revised September 3, 2016
  • Accepted September 8, 2016
  • First published October 19, 2016.
Online issue publication 
October 26, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.